Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB, RECOMBINANT Cause Disseminated tuberculosis? 7 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Disseminated tuberculosis have been filed in association with INFLIXIMAB, RECOMBINANT. This represents 2.8% of all adverse event reports for INFLIXIMAB, RECOMBINANT.

7
Reports of Disseminated tuberculosis with INFLIXIMAB, RECOMBINANT
2.8%
of all INFLIXIMAB, RECOMBINANT reports
0
Deaths
2
Hospitalizations

How Dangerous Is Disseminated tuberculosis From INFLIXIMAB, RECOMBINANT?

Of the 7 reports, 2 (28.6%) required hospitalization.

Is Disseminated tuberculosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB, RECOMBINANT. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB, RECOMBINANT Cause?

Pneumocystis jirovecii pneumonia (29) Off label use (21) Infusion related reaction (18) Histoplasmosis disseminated (16) Tuberculosis (15) Lupus-like syndrome (13) Pulmonary tuberculosis (12) Drug ineffective (11) Pneumonia (11) Crohn's disease (9)

What Other Drugs Cause Disseminated tuberculosis?

INFLIXIMAB (341) ADALIMUMAB (258) PREDNISONE (179) PREDNISOLONE (176) TACROLIMUS (174) METHOTREXATE (170) MYCOPHENOLATE MOFETIL (144) ISONIAZID (117) ETHAMBUTOL (114) RIFAMPIN (113)

Which INFLIXIMAB, RECOMBINANT Alternatives Have Lower Disseminated tuberculosis Risk?

INFLIXIMAB, RECOMBINANT vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB, RECOMBINANT vs INFLUENZA VIRUS VACCINE INFLIXIMAB, RECOMBINANT vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B INFLIXIMAB, RECOMBINANT vs INGENOL MEBUTATE INFLIXIMAB, RECOMBINANT vs INLYTA

Related Pages

INFLIXIMAB, RECOMBINANT Full Profile All Disseminated tuberculosis Reports All Drugs Causing Disseminated tuberculosis INFLIXIMAB, RECOMBINANT Demographics